Olongapo City starts vaccinating indigent residents vs COVID-19 | Inquirer News

Olongapo City starts vaccinating indigent residents vs COVID-19

/ 04:29 PM September 24, 2021

Eligible residents of Olongapo City continue to flock to the SMX Convention of the SM Olongapo to get inoculated against COVID-19. (Photo courtesy of Olongapo City Information Center)

OLONGAPO CITY––The local government has begun vaccinating eligible residents belonging to the A5 category or indigent sector as it inches closer to achieving herd immunity from COVID-19, the city health office (CHO) said Friday, Sept. 24.

The city has vaccinated 69,382 healthcare workers, senior citizens, persons with comorbidities, and essential workers.

ADVERTISEMENT

Of these, at least 30,139 have been fully vaccinated against the viral disease.

FEATURED STORIES

The city uses two venues to speed up its mass vaccination–the SMX Convention Center of SM Olongapo and the Rizal Triangle covered court.

On Friday, the local government targeted to inoculate at least 2,500 more residents for their second dose of the Sinovac or Pfizer vaccine.

The city needs to vaccinate 182,000 of its 260,000-population to achieve herd immunity against COVID-19. INQ

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, indigents, Olongapo City, Regions, Vaccination

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.